par Wolking, Stefan;Campbell, Ciarán;Stapleton, Caragh;McCormack, Mark;Delanty, Norman;Depondt, Chantal ;Johnson, Michael;Koeleman, Bobby B.P.C.;Krause, Roland;Kunz, Wolfram W.S.;Marson, Anthony Guy;Sander, Josemir W;Sills, Graeme;Striano, Pasquale;Zara, Federico;Sisodiya, Sanjay;Cavalleri, Gianpiero;Lerche, Holger
Référence Frontiers in Pharmacology, 12, 688386
Publication Publié, 2021-06
Référence Frontiers in Pharmacology, 12, 688386
Publication Publié, 2021-06
Article révisé par les pairs
Titre: |
|
Auteur: | Wolking, Stefan; Campbell, Ciarán; Stapleton, Caragh; McCormack, Mark; Delanty, Norman; Depondt, Chantal; Johnson, Michael; Koeleman, Bobby B.P.C.; Krause, Roland; Kunz, Wolfram W.S.; Marson, Anthony Guy; Sander, Josemir W; Sills, Graeme; Striano, Pasquale; Zara, Federico; Sisodiya, Sanjay; Cavalleri, Gianpiero; Lerche, Holger |
Informations sur la publication: | Frontiers in Pharmacology, 12, 688386 |
Statut de publication: | Publié, 2021-06 |
Sujet CREF: | Pharmacologie |
Mots-clés: | anti-seizure medication (ASM) |
drug-resistant epilepsies | |
GWAS | |
polygenic risk score (PRS) | |
single nucelotide polymorphisms | |
Note générale: | SCOPUS: ar.j |
Langue: | Anglais |
Identificateurs: | urn:issn:1663-9812 |
info:doi/10.3389/fphar.2021.688386 | |
info:scp/85108615241 |